ACRO Biomedical uses Supercritical carbon dioxide or scCO2 to minimally manipulate the natural biomaterial to make sure they retain their natural mechanical strength and porosity. Essentially, this is the process by which the biomaterials are made safe and clinically effective. It's this technology that gives ACRO Biomedical the advantage over other xenograft-based manufacturers.